{"nct_id":"NCT05722015","title":"A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2023-02-14","start_date_type":"ACTUAL","primary_completion_date":"2024-07-12","primary_completion_date_type":"ACTUAL","completion_date":"2028-05-22","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}